Michael Rivner


Michael Rivner


Academic Appointment(s)

Medical College of Georgia
Department of Neurology

Emeritus Faculty

Medical College of Georgia
Department of Neuroscience and Regenerative Medicine

The Graduate School


I am a specialist in Neuromuscular diseases. I established and run the ALS clinic. I have research grants in Myasthenia Gravis and ALS. I run the EMG lab at AUHealth. I also have an interest in botulinum toxins.

  • (706) 721-2681
  • (706) 721-8701
  • BP 4390


  • MD, Medicine Emory University, 1978

  • BA, Psychology, General Duke University, 1972

  • BA, Zoology/Animal Biology Duke University, 1972


  • PHY GA Composite Medical Brd, 1979

  • BLS 2014

Courses Taught Most Recent Academic Year

  • NEUR 5000

    Basic Clkshp in Neurology
  • RNEU 5000


Teaching Interests

EMG, ALS, Myasthenia Gravis, Neuromuscular diseases, botulinum toxin


Selected Recent Publications

  • Induction of anti-agrin antibodies causes myasthenia gravis in mice, 2018
    Journal Article, Academic Journal
  • Agrin and LRP4 antibodies in Amyotrophic Lateral Sclerosis Patients, 2017
    Journal Article, Academic Journal
  • Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study, 2017
    Journal Article, Academic Journal
  • Phase IIA Trial of Fingolimod for ALS Demonstrates Acceptable Acute Safety and Tolerability, 2017
    Journal Article, Academic Journal
  • Screening for llipoprotein receptor-related protein 4-, agrin-, and titin-antibodies and exploring the autoimmune spectrum in myasthenia gravis, 2017
    Journal Article, Academic Journal

Research Interests

Myasthenia Gravis
Botulinum Toxins

Professional Service

  • ALS Clinic 2007 - 2018

    Role: Director
  • EMG Lab 1983 - 2018

    Role: Director